Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00266877 · COMPLETED

Trial details

NCT number: NCT00266877
Sponsor: Puma Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Start date: 2005-12-01
Primary completion: 2009-01-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.